|
|
Article: GlaxoSmithKline Consumer Healthcare Adds Rx Dermatology Products to Its Portfolio.
- Article from:
- PR Newswire
- Article date:
- December 23, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GlaxoSmithKline Consumer Healthcare, a division of GlaxoSmithKline Corporation , announced today that it has obtained five dermatology products from Elan Pharmaceuticals, which is exiting the dermatology business.
Beginning January 1, 2003, GSK Consumer Healthcare will market Aclovate(R), Cutivate(R), Temovate(R), Oxistat(R), and Emgel(R).
"These proven pharmaceutical products are an excellent fit with our over- the-counter brands, including Oxy(R) acne products and Abreva(R) cold sore medication," said Manfred Scheske, president, GlaxoSmithKline Consumer Healthcare North America. "Many of our existing products, including Ecotrin, Citrucel and Os-Cal, ...